Category: Edwards LifesciencesSyndicate content

CardioKinetix signs option-to-buy agreement with Edwards Lifesciences; raises $50M | Medtech funding for the week of December 8, 2014

December 12, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: CardioKinetix raises $50m, inks buyout deal with Edwards Lifesciences; Angel Medical raises $10m for ischemia devices; Zyga Technology raises $2m; Image Stream Medical looks at $8m

CardioKinetix raises $50m, inks buyout deal with Edwards Lifesciences

December 8, 2014 by Val Kennedy

Study buoys Medtronic, Edwards valves in bicuspid disease

December 11, 2014 by Mark Hollmer

A clinical study delivers positive results for replacement heart valves made by rivals Edwards Lifesciences and Medtronic in treating bicuspid disease.

Study buoys Medtronic, Edwards valves in bicuspid disease

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Edwards CEO Mussallem hopes FDA to accelerate approvals of medical devices

December 9, 2014 by MassDevice

Michael Mussallem, CEO, Edwards Lifesciences says FDA regulators are looking to speed up approvals for medical devices

Edwards CEO talks innovation and regulation on Capitol Hill

(Reuters) - U.S. health regulators appear open to speeding up approvals of medical devices that currently often reach European markets three to five years ahead of being cleared in the United States, the chief executive officer of Edwards Lifesciences (NYSE:EW) said.

CardioKinetix raises $50m, inks buyout deal with Edwards Lifesciences

December 8, 2014 by Val Kennedy

CardioKinetix signs an exclusive option-to-buy agreement with Edwards Lifesciences in connection with a $50 million financing round.

CardioKinetix raises $50m, inks buyout deal with Edwards Lifesciences

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Edwards Lifesciences affirms guidance, ups stake in CardioKinetix, lures Medtronic exec

December 8, 2014 by Brad Perriello

Edwards Lifesciences affirms its outlook for 2014 and reveals its 2015 guidance, along with an increased investment in CardioKinetix and a new leader for its critical care business lured from Medtronic.

Edwards Lifesciences affirms guidance, ups stake in CardioKinetix, lures Medtronic exec

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Edwards Lifesciences posts double-digit Q3 sales, earnings increases

October 23, 2014 by Brad Perriello

Edwards Lifesciences reports 3rd-quarter sales and earnings growth in excess of 20% and raises its outlook for the rest of the year.

Edwards Lifesciences posts double-digit Q3 sales, earnings increases

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp